CME Group ROE 2012-2026 | CME
Current and historical return on equity (ROE) values for CME Group (CME) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| CME Group ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2026-03-31 | $4.23B | $27.82B | 15.21% |
| 2025-12-31 | $4.02B | $27.92B | 14.40% |
| 2025-09-30 | $3.72B | $27.36B | 13.58% |
| 2025-06-30 | $3.72B | $27.37B | 13.60% |
| 2025-03-31 | $3.58B | $27.34B | 13.10% |
| 2024-12-31 | $3.48B | $27.37B | 12.72% |
| 2024-09-30 | $3.42B | $27.44B | 12.47% |
| 2024-06-30 | $3.26B | $27.42B | 11.89% |
| 2024-03-31 | $3.16B | $27.47B | 11.49% |
| 2023-12-31 | $3.19B | $27.52B | 11.58% |
| 2023-09-30 | $3.01B | $27.56B | 10.93% |
| 2023-06-30 | $2.94B | $27.58B | 10.67% |
| 2023-03-31 | $2.83B | $27.63B | 10.24% |
| 2022-12-31 | $2.66B | $27.72B | 9.59% |
| 2022-09-30 | $2.63B | $27.85B | 9.46% |
| 2022-06-30 | $2.89B | $27.61B | 10.47% |
| 2022-03-31 | $2.75B | $27.30B | 10.05% |
| 2021-12-31 | $2.62B | $27.01B | 9.69% |
| 2021-09-30 | $2.44B | $26.74B | 9.10% |
| 2021-06-30 | $1.92B | $26.68B | 7.20% |
| 2021-03-31 | $1.91B | $26.69B | 7.17% |
| 2020-12-31 | $2.11B | $26.70B | 7.88% |
| 2020-09-30 | $2.15B | $26.65B | 8.07% |
| 2020-06-30 | $2.38B | $26.60B | 8.93% |
| 2020-03-31 | $2.39B | $26.51B | 9.00% |
| 2019-12-31 | $2.12B | $26.41B | 8.02% |
| 2019-09-30 | $2.03B | $26.36B | 7.71% |
| 2019-06-30 | $1.81B | $25.48B | 7.09% |
| 2019-03-31 | $1.86B | $24.64B | 7.55% |
| 2018-12-31 | $1.96B | $23.79B | 8.25% |
| 2018-09-30 | $4.52B | $22.90B | 19.72% |
| 2018-06-30 | $4.41B | $22.29B | 19.80% |
| 2018-03-31 | $4.26B | $21.71B | 19.64% |
| 2017-12-31 | $4.06B | $21.15B | 19.21% |
| 2017-09-30 | $1.50B | $20.63B | 7.26% |
| 2017-06-30 | $1.66B | $20.73B | 8.02% |
| 2017-03-31 | $1.57B | $20.81B | 7.53% |
| 2016-12-31 | $1.53B | $20.88B | 7.35% |
| 2016-09-30 | $1.45B | $20.93B | 6.94% |
| 2016-06-30 | $1.34B | $20.96B | 6.39% |
| 2016-03-31 | $1.29B | $21.01B | 6.12% |
| 2015-12-31 | $1.25B | $21.07B | 5.92% |
| 2015-09-30 | $1.26B | $21.16B | 5.96% |
| 2015-06-30 | $1.19B | $21.20B | 5.62% |
| 2015-03-31 | $1.19B | $21.26B | 5.60% |
| 2014-12-31 | $1.13B | $21.31B | 5.29% |
| 2014-09-30 | $1.01B | $21.37B | 4.75% |
| 2014-06-30 | $0.96B | $21.48B | 4.47% |
| 2014-03-31 | $1.01B | $21.58B | 4.67% |
| 2013-12-31 | $0.98B | $21.64B | 4.52% |
| 2013-09-30 | $0.95B | $21.70B | 4.38% |
| 2013-06-30 | $0.93B | $21.64B | 4.31% |
| 2013-03-31 | $0.87B | $21.58B | 4.01% |
| 2012-12-31 | $0.90B | $21.58B | 4.16% |
| 2012-09-30 | $1.48B | $21.61B | 6.83% |
| 2012-06-30 | $1.57B | $21.40B | 7.36% |
| 2012-03-31 | $1.62B | $21.22B | 7.65% |
| 2011-12-31 | $1.81B | $21.03B | 8.62% |
| 2011-09-30 | $1.26B | $20.65B | 6.12% |
| 2011-06-30 | $1.19B | $20.41B | 5.83% |
| 2011-03-31 | $1.17B | $20.03B | 5.83% |
| 2010-12-31 | $0.95B | $19.63B | 4.84% |
| 2010-09-30 | $0.96B | $19.44B | 4.93% |
| 2010-06-30 | $0.92B | $19.25B | 4.76% |
| 2010-03-31 | $0.87B | $19.15B | 4.53% |
| 2009-12-31 | $0.83B | $19.05B | 4.34% |
| 2009-09-30 | $0.69B | $18.90B | 3.62% |
| 2009-06-30 | $0.65B | $18.88B | 3.45% |
| 2009-03-31 | $0.63B | $17.46B | 3.61% |
| 2008-12-31 | $0.72B | $16.06B | 4.46% |
| 2008-09-30 | $0.86B | $14.46B | 5.91% |
| 2008-06-30 | $0.89B | $12.73B | 6.98% |
| 2008-03-31 | $0.81B | $9.83B | 8.27% |
| 2007-12-31 | $0.66B | $6.95B | 9.49% |
| 2007-09-30 | $0.56B | $4.25B | 13.20% |
| 2007-06-30 | $0.46B | $1.58B | 29.36% |
| 2007-03-31 | $0.45B | $1.47B | 30.42% |
| 2006-12-31 | $0.41B | $1.36B | 29.91% |
| 2006-09-30 | $0.38B | $1.26B | 30.14% |
| 2006-06-30 | $0.35B | $1.17B | 30.29% |
| 2006-03-31 | $0.33B | $1.08B | 30.16% |
| 2005-12-31 | $0.31B | $1.00B | 30.63% |
| 2005-09-30 | $0.29B | $0.92B | 31.11% |
| 2005-06-30 | $0.27B | $0.85B | 31.64% |
| 2005-03-31 | $0.24B | $0.78B | 31.14% |
| 2004-12-31 | $0.22B | $0.72B | 30.64% |
| 2004-09-30 | $0.19B | $0.65B | 29.44% |
| 2004-06-30 | $0.16B | $0.60B | 27.38% |
| 2004-03-31 | $0.14B | $0.55B | 25.72% |
| 2003-12-31 | $0.12B | $0.52B | 23.54% |
| 2003-09-30 | $0.12B | $0.49B | 25.36% |
| 2003-06-30 | $0.12B | $0.43B | 26.99% |
| 2003-03-31 | $0.10B | $0.37B | 27.36% |
| 2002-12-31 | $0.10B | $0.32B | 29.37% |
| 2002-09-30 | $0.09B | $0.27B | 31.39% |
| 2002-06-30 | $0.08B | $0.20B | 40.70% |
| 2002-03-31 | $0.07B | $0.13B | 57.03% |
| 2001-12-31 | $0.08B | $0.06B | 120.97% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Finance | Securities Exchanges | $105.902B | $6.521B |
| CME Group is the largest futures exchange in the world in terms of trading volume as well as notional value traded. CME Group offers a broad range of products covering major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. Trades are executed through CME Group's electronic trading platforms, open outcry and privately negotiated transactions. CME Group also operates one of the world's leading central counterparty clearing providers through CME Clearing and CME Clearing Europe, which offer clearing and settlement services across asset classes for exchange-traded and over-the-counter derivatives. Apart from CME and CBOT, the company operates New York Mercantile Exchange, Inc. (NYMEX) and Commodity Exchange, Inc. (COMEX), CME Clearing Europe Limited (CMECE) and CME Europe Limited (CME Europe). The company reports the results of its operations as one operating segment mainly comprised of CME, CBOT, NYMEX and COMEX. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| S&P Global (SPGI) | United States | $126.065B | 23.30 |
| Intercontinental Exchange (ICE) | United States | $90.969B | 23.11 |
| London Stock Exchange Group - (LSEGY) | United Kingdom | $61.205B | 0.00 |
| Deutsche Boerse AG (DBOEY) | Germany | $53.734B | 22.39 |
| Nasdaq (NDAQ) | United States | $47.272B | 23.90 |
| OTC Markets Group (OTCM) | United States | $0.648B | 20.93 |